Renal cell carcinoma

Common Name(s)

Renal cell carcinoma

Renal cell carcinoma (RCC) is one of the most common types of kidney cancers seen in adults. RCC occurs more often in men between the ages of 50 to 70. The kidneys help get rid of waste in the body. There are small tubes in the kidneys that help filter waste from the blood and help make urine. RCC occurs when cells start growing uncontrollably in the lining of these small tubes. Symptoms may not appear in the early stages of renal cell carcinoma, which is why renal cell carcinoma is normally advanced when found. Later symptoms may include blood in urine, a lump in the abdomen, weight loss, anemia, and loss of appetite. If untreated, it may spread to the lymph nodes, lungs, liver, adrenal glands, brain, or bones.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Renal cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Renal cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Renal cell carcinoma" returned 2819 free, full-text research articles on human participants. First 3 results:

[Urinary metabolomics study of renal cell carcinoma based on gas chromatography-mass spectrometry].
 

Author(s): Lin Zhang, Ling Li, Hairui Kong, Fangyin Zeng

Journal: Nan Fang Yi Ke Da Xue Xue Bao. 2015 May;35(5):763-6.

 

To identify the biomarkers of renal cell cancer (RCC) through urine metabolic analysis.

Last Updated: 28 May 2015

Go To URL
Oncological and functional outcomes of salvage renal surgery following failed primary intervention for renal cell carcinoma.
 

Author(s): Fernando G Abarzua-Cabezas, Einar Sverrisson, Robert De La Cruz, Philippe E Spiess, Peter Haddock, Wade J Sexton

Journal: Int Braz J Urol. ;41(1):147-54.

 

To assess the oncologic and functional outcomes of salvage renal surgery following failed primary intervention for RCC.

Last Updated: 1 May 2015

Go To URL
Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients.
 

Author(s): Hideyuki Akaza, Seiji Naito, Naomi Ueno, Kouji Aoki, Hiroyuki Houzawa, Susan Pitman Lowenthal, Sang-Yoon Lee

Journal: Jpn. J. Clin. Oncol.. 2015 Jun;45(6):576-83.

 

This prospective, post-marketing study collected sunitinib safety and efficacy data in Japanese patients with unresectable/metastatic renal cell carcinoma. Retrospective analysis investigated adverse events as potential sunitinib efficacy biomarkers.

Last Updated: 10 Jun 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Renal cell carcinoma" returned 298 free, full-text review articles on human participants. First 3 results:

Imaging findings of common benign renal tumors in the era of small renal masses: differential diagnosis from small renal cell carcinoma: current status and future perspectives.
 

Author(s): Sungmin Woo, Jeong Yeon Cho

Journal: Korean J Radiol. ;16(1):99-113.

 

The prevalence of small renal masses (SRM) has risen, paralleling the increased usage of cross-sectional imaging. A large proportion of these SRMs are not malignant, and do not require invasive treatment such as nephrectomy. Therefore, differentiation between early renal cell carcinoma ...

Last Updated: 19 Jan 2015

Go To URL
Low enhancing papillary renal cell carcinoma diagnosed by using dual energy computerized tomography: a case report and review of literature.
 

Author(s): Shaheen Alanee, Danuta I Dynda, Patrick Hemmer, Bradley Schwartz

Journal:

 

Papillary renal cell carcinoma (pRCC) is a mixed group of tumors that constitutes about 15-20% of all renal cortical cancers. Strong enhancement on computerized tomography (CT) is a feature of clear cell, but not of pRCC making the differentiation of papillary tumors from benign cysts ...

Last Updated: 6 Jan 2015

Go To URL
Risk factors for renal cell carcinoma in a Japanese population.
 

Author(s): Masakazu Washio, Mitsuru Mori, Kazuya Mikami, Tsuneharu Miki, Yoshiyuki Watanabe, Masahiro Nakao, Tatsuhiko Kubo, Koji Suzuki, Kotaro Ozasa, Kenji Wakai, Akiko Tamakoshi

Journal: Asian Pac. J. Cancer Prev.. 2014 ;15(21):9065-70.

 

The incidence of renal cell carcinoma (RCC) is high in Western and Northern Europe and North America, and low in Asia. Although the incidence of RCC in Japan is lower than the rates in the other industrialized countries, there is no doubt that it is increasing. In this paper, we would ...

Last Updated: 25 Nov 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Immunotherapy Study for Metastatic Renal Cell Cancer
 

Status: Recruiting

Condition Summary: Metastatic Renal Cell Carcinoma; Metastatic Clear-cell Renal Cancer; Recurrent Renal Cell Carcinoma; Refractory Renal Cell Carcinoma; Metastatic Kidney Cancer

 

Last Updated: 6 Jul 2015

Go to URL
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma
 

Status: Recruiting

Condition Summary: ccRCC; RCC; Kidney Cancer; Clear Cell Renal Cell Carcinoma; Renal Cell Carcinoma

 

Last Updated: 6 Aug 2015

Go to URL
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
 

Status: Recruiting

Condition Summary: Renal Cell Carcinoma; Hereditary Leiomyomatosis and Renal Cell Cancer; Papillary Renal Cell Carcinoma, Sporadic

 

Last Updated: 18 Jul 2015

Go to URL